197 related articles for article (PubMed ID: 30981561)
21. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
[TBL] [Abstract][Full Text] [Related]
22. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
23. Very early diagnosis of systemic sclerosis.
Bellando-Randone S; Guiducci S; Matucci-Cerinic M
Pol Arch Med Wewn; 2012; 122 Suppl 1():18-23. PubMed ID: 23222375
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
25. Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting.
Kuwana M
J Nippon Med Sch; 2017; 84(2):56-63. PubMed ID: 28502960
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Systemic Sclerosis patients with positive anti-Th/To antibodies: About 6 patients and literature review.
Muller R; Benyamine A; Bertin D; Harlé JR; Kaplanski G; Mazodier K; Reynaud-Gaubert M; Granel B; Bardin N
Rev Med Interne; 2020 Jul; 41(7):440-445. PubMed ID: 32063422
[TBL] [Abstract][Full Text] [Related]
27. Criteria for the classification of early systemic sclerosis.
LeRoy EC; Medsger TA
J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
[TBL] [Abstract][Full Text] [Related]
28. Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice.
Jordan S; Maurer B; Toniolo M; Michel B; Distler O
Rheumatology (Oxford); 2015 Aug; 54(8):1454-8. PubMed ID: 25762528
[TBL] [Abstract][Full Text] [Related]
29. Red flags in scleroderma.
Li Q; Sahhar J; Littlejohn G
Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
[TBL] [Abstract][Full Text] [Related]
30. Update on systemic sclerosis.
McCray CJ; Mayes MD
Curr Allergy Asthma Rep; 2015 May; 15(5):25. PubMed ID: 26139334
[TBL] [Abstract][Full Text] [Related]
31. Nailfold Capillaroscopy - Its Role in Diagnosis and Differential Diagnosis of Microvascular Damage in Systemic Sclerosis.
Lambova S; Hermann W; Muller-Ladner U
Curr Rheumatol Rev; 2013; 9(4):254-60. PubMed ID: 26932290
[TBL] [Abstract][Full Text] [Related]
32. [Nail-fold capillaroscopy in dermatology].
Senet P; Fichel F; Baudot N; Gaitz JP; Tribout L; Frances C
Ann Dermatol Venereol; 2014; 141(6-7):429-37. PubMed ID: 24951141
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand.
Chang WS; Schollum J; White DH; Solanki KK
Clin Rheumatol; 2015 Nov; 34(11):1921-7. PubMed ID: 26022620
[TBL] [Abstract][Full Text] [Related]
34. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
Mierau R; Genth E
Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
[TBL] [Abstract][Full Text] [Related]
35. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Société française de médecine vasculaire].
Pistorius MA; Carpentier PH;
Ann Dermatol Venereol; 2013; 140(8-9):549-54. PubMed ID: 24034643
[TBL] [Abstract][Full Text] [Related]
36. [A case of systemic sclerosis].
Taieb D; Chauveau S; Khamis W; de Montmollin N; Sesé L; Duchemann B; Nunes H; Uzunhan Y
Rev Mal Respir; 2020 Apr; 37(4):341-345. PubMed ID: 32284205
[TBL] [Abstract][Full Text] [Related]
37. Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.
Araújo FC; Camargo CZ; Kayser C
Rheumatol Int; 2017 Nov; 37(11):1825-1833. PubMed ID: 28819792
[TBL] [Abstract][Full Text] [Related]
38. New Classification Criteria for Systemic Sclerosis (Scleroderma).
Pope JE; Johnson SR
Rheum Dis Clin North Am; 2015 Aug; 41(3):383-98. PubMed ID: 26210125
[TBL] [Abstract][Full Text] [Related]
39. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
Bellis R; Francès C; Barète S; Senet P
Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
[TBL] [Abstract][Full Text] [Related]
40. Nailfold capillaroscopy and classification criteria for systemic sclerosis.
Cutolo M; Matucci Cerinic M
Clin Exp Rheumatol; 2007; 25(5):663-5. PubMed ID: 18078610
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
